Mechanism of action of GP73 in the regulation of liver cancer: An analysis based on transcriptome sequencing

Peiling YE; Hongyun JIA; Liang PENG

doi:10.3969/j.issn.1001-5256.2021.08.022

Volume 37 Issue 8

Aug. 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(8): 1861-1866

PDF( 4393 KB)

Mechanism of action of GP73 in the regulation of liver cancer: An analysis based on transcriptome sequencing

DOI: 10.3969/j.issn.1001-5256.2021.08.022

1.
Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China
2.
Department of Clinical Laboratory, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China

Research funding:

Medical Scientific Research Fund of Guangdong Province (A2018153);

Science and Technology Project of Guangzhou Health and Family Planning Commission (20181A011072)

Received Date: 2021-01-20
Accepted Date: 2021-04-12
Published Date: 2021-08-20

Abstract

Abstract

Objective To investigate the mechanism of action of GP73 in the regulation of liver cancer based on transcriptome analysis. Methods Hepatoma Hep3B cells were divided into GP73 interference group, GP73 interference control group, GP73 overexpression group, and GP73 overexpression control group, and transcriptome sequencing was used to measure mRNA expression in the four groups. Differentially expressed genes were screened out based on sequencing data and were then analyzed by GO functional analysis and KEGG enrichment analysis. Western blot was used to verify the expression of signaling pathway-related proteins. The t-test was used for comparison of normally distributed continuous data between groups. Results The differentially expressed genes in Hep3B cells were analyzed after GP73 interference and overexpression. GO analysis revealed 586 biological processes, and GP73 was mainly involved in the processes such as cellular process, single-organism process, and biological regulation. KEGG analysis showed that GP73 was mainly involved in the signaling pathways closely associated with liver cancer, including the PI3K-AKT signaling pathway, the cytokine-cytokine receptor interaction signaling pathway, the TNF signaling pathway, and the JAK-STAT signaling pathway. Western blot was used to verify the three proteins PI3K, p-Akt, and Akt in the PI3K-AKT signaling pathway, and the results showed that there were significant differences in the expression of PI3K and p-Akt between the GP73 interference group and the GP73 interference control group and between the GP73 overexpression group and the GP73 overexpression control group (all P < 0.05). Conclusion The signaling pathways involving GP73 in the regulation of liver cancer are screened out by transcriptome sequencing and bioinformatics analysis, which provides new ideas for further elucidating the mechanism of action of GP73 in liver cancer.
- Liver Neoplasms,
- Transcriptome,
- Signal Transduction

FullText(HTML)

References(12)

References

[1]	PETRICK JL, FLORIO AA, ZNAOR A, et al. International trends in hepatocellular carcinoma incidence, 1978-2012[J]. Int J Cancer, 2020, 147(2): 317-330. DOI: 10.1002/ijc.32723.
[2]	LI JN, ZHENG RQ, LI N, et al. The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis[J]. J Clin Hepatol, 2019, 35(6): 1361-1364. DOI: 10.3969/j.issn.1001-5256.2019.06.040. 李佳娜, 郑瑞琦, 李娜, 等. 高尔基体蛋白73的生物学特征及在肝纤维化和肝硬化中的诊断价值[J]. 临床肝胆病杂志, 2019, 35(6): 1361-1364. DOI: 10.3969/j.issn.1001-5256.2019.06.040.
[3]	XIAO J, LONG F, PENG T, et al. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis[J]. Eur Rev Med Pharmacol Sci, 2019, 23(8): 3302-3310. DOI: 10.26355/eurrev_201904_17692.
[4]	JIAO C, CUI L, PIAO J, et al. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma[J]. J Cancer Res Ther, 2018, 14(6): 1239-1244. DOI: 10.4103/0973-1482.199784.
[5]	KE MY, WU XN, ZHANG Y, et al. Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma[J]. J Transl Med, 2019, 17(1): 140. DOI: 10.1186/s12967-019-1889-0.
[6]	CHEN M, ZHAO K, LIU PC, et al. Effects of silencing GP73 with siRNA interference on the migration and invasion of human hepatoma HepG2 cells[J]. J Shanghai Jiaotong Univ (Med Sci), 2016, 36(11): 1588-1593. DOI: 10.3969/j.issn.1674-8115.2016.11.009. 陈默, 赵坤, 柳鹏程, 等. RNA干扰技术沉默GP73对人肝癌HepG2细胞迁移和侵袭的影响[J]. 上海交通大学学报(医学版), 2016, 36(11): 1588-1593. DOI: 10.3969/j.issn.1674-8115.2016.11.009.
[7]	KLADNEY RD, BULLA GA, GUO L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection[J]. Gene, 2000, 249(1-2): 53-65. DOI: 10.1016/s0378-1119(00)00136-0.
[8]	YE PL, HE XX, WU XM. Expression of GP73 in liver tissue of primary liver cancer[J]. Guangdong Med J, 2014, 35(2): 234-236. DOI: 10.13820/j.cnki.gdyx.2014.02.025. 叶佩灵, 何欣欣, 吴晓蔓. 原发性肝癌组织中GP73蛋白的表达[J]. 广东医学, 2014, 35(2): 234-236. DOI: 10.13820/j.cnki.gdyx.2014.02.025.
[9]	YE PL, WU XM. Significance of GP73 level in primary hepatocellular carcinoma[J]. J Hainan Med Univ, 2014, 20(1): 83-86, 89. DOI: 10.13210/j.cnki.jhmu.2014.01.033. 叶佩灵, 吴晓蔓. 高尔基体糖蛋白73在原发性肝癌中的表达及意义[J]. 海南医学院学报, 2014, 20(1): 83-86, 89. DOI: 10.13210/j.cnki.jhmu.2014.01.033.
[10]	YE PL, WU XM. The significance of combined detection of serum Golgi protein 73, AFP, CEA, CA199 and GGT in the early diagnosis of primary hepatic carcinoma[J]. J Tropical Med, 2016, 16(4): 467-470. 叶佩灵, 吴晓蔓. 血清GP73联合AFP、CEA、CA199、GGT检测在PHC早期筛查的应用价值[J]. 热带医学杂志, 2016, 16(4): 467-470.
[11]	YANG Y, LIU Q, LI Z, et al. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma[J]. Carcinogenesis, 2018, 39(7): 900-910. DOI: 10.1093/carcin/bgy010.
[12]	YANG Y, LIU Q, ZHANG H, et al. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma[J]. Oncol Rep, 2017, 37(2): 1182-1188. DOI: 10.3892/or.2017.5351.

Relative Articles

[1]	Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018
[2]	Zhiguo LI, Xun MA, Yongan YE, Xianzhao YANG. Regulatory effect of Kangxian Yiai Prescription in a rat model of precancerous lesions of liver cancer： A study based on the mTOR/HIF-1α/VEGF signaling pathway[J]. Journal of Clinical Hepatology, 2024, 40(10): 2049-2054. doi: 10.12449/JCH241019
[3]	Xing YANG, Shudi LI, Jiangkai LIU, Zhen WANG, Suling LI. Current research status of traditional Chinese medicine in the prevention and treatment of hepatocellular carcinoma by regulating the JAK/STAT signaling pathway[J]. Journal of Clinical Hepatology, 2023, 39(11): 2718-2729. doi: 10.3969/j.issn.1001-5256.2023.11.030
[4]	Rui SONG, Jing LI, Hongju YANG, Minyue LI, Jing YOU. Role of signal transducer and activator of transcription 1 in regulation of Treg/Th17 balance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2627-2631. doi: 10.3969/j.issn.1001-5256.2022.11.038
[5]	Gerui ZHU, Jing WANG, Kai HUANG, Yuan PENG, Chenghai LIU, Yanyan TAO. A transcriptomic analysis of acute hepatotoxicity induced by aristolochic acid Ⅰ in mice[J]. Journal of Clinical Hepatology, 2021, 37(10): 2389-2394. doi: 10.3969/j.issn.1001-5256.2021.10.026
[6]	WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018
[7]	Hong YingHui, Wang Chun, Ye MingLiang, Luo Jie, Liu JiaLiang, Ren Chao, Lan SiYu, Zhao Qiu, Chang Ying. Role of the Hippo signaling pathway in the development and progression of primary liver cancer[J]. Journal of Clinical Hepatology, 2020, 36(5): 1171-1174. doi: 10.3969/j.issn.1001-5256.2020.05.050
[8]	ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006
[9]	Kong Li, Zhang YuZhuo, Jin Meng, Wang ShanShan, Du JingHua, Zhang YuGuo, Wang RongQi, Ren WeiGuang, Nan YueMin. mRNA expression and significance of tumor necrosis factor-alpha-induced protein 8-like 2 and forkhead box P3 in peripheral blood mononuclear cells in patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2019, 35(12): 2721-2724. doi: 10.3969/j.issn.1001-5256.2019.12.016
[10]	Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042
[11]	Zhang Xin, Wang MuQi, Wang WenJun, Li YaPing, Shi JuanJuan, Li Mei, Jia XiaoLi, Dang ShuangSuo. A bioinformatics analysis of differentially expressed genes in Huh7 cells with low expression of Mindin[J]. Journal of Clinical Hepatology, 2019, 35(10): 2272-2277. doi: 10.3969/j.issn.1001-5256.2019.10.028
[12]	Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033
[13]	Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014
[14]	Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048
[15]	Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001
[16]	Gou ZePeng, Wang DeSheng, Zhou Liang, Zhu PuLi, Zhang Yong, Sun Wei. The research progress of STAT3 on the regulation of hepatocellular carcinoma invasion and metastasis[J]. Journal of Clinical Hepatology, 2012, 28(4): 308-311.
[17]	Xie XueHai, Hao Kun, Yang YinMo. Hedgehog signaling pathway and pancreatic cancer[J]. Journal of Clinical Hepatology, 2010, 26(5): 468-471+478.
[19]	Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	黄秀娜，邝振展，张蓉，张志英，程琰. 利用转录组学数据研究健康人骨髓红系细胞基因表达的差异. 解放军医药杂志. 2022(01): 1-6 .
2.	黄创新，李峥嶸. PIVKA-Ⅱ、GP73、AFP-L3在肝细胞癌患者中的表达及诊断价值研究. 医学理论与实践. 2022(16): 2814-2816 .
3.	刘旭初，覃世运，陈丽君，陈娟，尤晓光. KRAS基因突变对经肝动脉化疗栓塞术治疗的中晚期原发性肝癌患者预后的预测价值. 临床肝胆病杂志. 2022(11): 2514-2519 . 本站查看

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(7) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (820) PDF downloads(52)

Mechanism of action of GP73 in the regulation of liver cancer: An analysis based on transcriptome sequencing

DOI: 10.3969/j.issn.1001-5256.2021.08.022